CW August 2004
Volume 13Issue Number 8 August 2004 ISSN 10593802 Pemetrexed: A Novel Antifolate Agent Enters Clinical PracticeAlimta is the first and only drug approved by the US Food and Drug Administration for use with cisplatin in the treatment of malignant pleural mesothelioma, a cancer of the lining of the lungs often associated with asbestos exposure.
Go to Previous Page Go to Next Page Source & Additional Reading Expert Rev Anticancer Ther., August 4, 2004. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW August 2004Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
